trial

Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia

NCTId NCT01012830
as of 2026-07-01
at a glance
Phase 4 · Unknown
Enrollment 15 (estimated)
Primary completion 2010-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Unknown
Enrollment
15 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2009-12
Primary completion
2010-12
Eligibility
ALL · 19 Years · 59 Years

Interventions & indications

Sponsors

Investigators

1
Prasad R Padala, MD, MSPrincipal Investigator

Sites

1 total
Omaha, United States

Facts & assertions

4 sourced
Enrollment
15
Phase
PHASE4
Primary Completion Date
2010-12
Status
UNKNOWN
relationships
The graph out of here
drug
indication
indication
indication
investigator